CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.163
EU - Europa 9.122
AS - Asia 8.621
AF - Africa 765
SA - Sud America 602
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 31
Totale 31.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.042
SG - Singapore 2.546
CN - Cina 2.511
GB - Regno Unito 2.284
IT - Italia 2.237
VN - Vietnam 1.636
DE - Germania 1.140
SE - Svezia 768
HK - Hong Kong 765
UA - Ucraina 539
IN - India 502
RU - Federazione Russa 486
BR - Brasile 453
FR - Francia 323
IE - Irlanda 323
NL - Olanda 269
CI - Costa d'Avorio 225
TG - Togo 216
ZA - Sudafrica 177
KR - Corea 170
JP - Giappone 146
EE - Estonia 144
FI - Finlandia 98
JO - Giordania 83
CH - Svizzera 77
CA - Canada 76
HR - Croazia 73
BG - Bulgaria 72
BE - Belgio 71
AR - Argentina 67
ID - Indonesia 58
AT - Austria 50
SC - Seychelles 48
NG - Nigeria 47
PL - Polonia 41
EU - Europa 34
GR - Grecia 29
MX - Messico 29
EC - Ecuador 26
ES - Italia 26
AU - Australia 23
BD - Bangladesh 21
TR - Turchia 20
LT - Lituania 19
TW - Taiwan 19
UZ - Uzbekistan 18
SA - Arabia Saudita 16
IR - Iran 15
PH - Filippine 15
CL - Cile 14
RO - Romania 14
CO - Colombia 13
CZ - Repubblica Ceca 13
TH - Thailandia 13
EG - Egitto 11
IL - Israele 10
LB - Libano 10
PE - Perù 10
PT - Portogallo 10
DZ - Algeria 9
KE - Kenya 9
MA - Marocco 8
NZ - Nuova Zelanda 8
TN - Tunisia 8
VE - Venezuela 8
MY - Malesia 6
PY - Paraguay 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
IQ - Iraq 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
OM - Oman 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
MD - Moldavia 1
Totale 31.330
Salva come PNG Salva come JPEG
Città #
Southend 2.005
Singapore 1.753
Fairfield 1.279
Ashburn 1.098
Chandler 939
Hong Kong 744
Dong Ket 656
Wilmington 622
Woodbridge 574
Seattle 561
Ann Arbor 543
Santa Clara 522
Princeton 493
Houston 483
Hefei 451
Cambridge 431
Bologna 389
Beijing 385
Dublin 315
Boardman 302
Jacksonville 278
Ho Chi Minh City 252
Abidjan 225
Lomé 216
Westminster 187
Hanoi 185
Padova 177
Los Angeles 171
Nanjing 170
Seoul 158
Dallas 150
Berlin 149
Milan 141
Tokyo 121
Rome 119
Buffalo 117
Redmond 115
New York 111
Saint Petersburg 102
San Diego 90
Jinan 89
Amman 83
Turin 81
Medford 76
Shenyang 73
Sofia 72
Bremen 71
Brussels 69
Helsinki 65
Redondo Beach 63
Shanghai 62
Nanchang 61
Changsha 60
Hebei 60
Bern 58
Falls Church 58
Munich 58
Mülheim 58
Florence 57
Verona 51
São Paulo 50
Guangzhou 49
Tianjin 47
Zhengzhou 46
Jiaxing 44
Dearborn 43
London 42
Bengaluru 41
Toronto 39
Abeokuta 38
Des Moines 38
Jakarta 36
Frankfurt am Main 34
Chicago 33
Yubileyny 33
Mahé 31
The Dalles 31
Redwood City 30
Hangzhou 28
Ningbo 28
Phoenix 28
Vienna 28
Norwalk 27
Olalla 27
Falkenstein 26
Council Bluffs 25
Biella 24
Da Nang 24
Modena 24
Bühl 23
Haiphong 22
Shenzhen 21
Naples 20
Nuremberg 20
Wuhan 20
Taipei 19
Taizhou 19
Biên Hòa 18
Kunming 18
Turku 18
Totale 20.316
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 678
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 468
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 293
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 275
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 270
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 263
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 238
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 231
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 228
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 228
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 228
Diagnosis and therapy of irritable bowel syndrome 225
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 223
Elementi di Farmacologia: Compendio per l’esame. 218
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 212
Antibacterial macrolides: a drug class with a complex pharmacological profile 208
Farmacologia. Azioni e Reazioni dei farmaci. 206
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 203
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 201
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 197
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 195
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 193
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 193
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 189
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 187
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 185
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 185
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 184
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 183
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 181
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 180
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 179
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 179
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 178
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 174
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 173
An update on the first decade of the European centralized procedure: how many innovative drugs? 173
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 171
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 169
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 168
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 167
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 166
Paraneoplastic Syndrome 165
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 165
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 165
Social and clinical descriptors of antipsychotic prescription 164
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 164
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 163
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 162
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 162
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 159
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 159
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 157
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 157
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 157
Academic output from EU-funded health research projects 155
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 155
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 155
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 153
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 153
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 153
Drug-induced Kounis syndrome: A matter of pharmacovigilance 153
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 152
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 152
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 152
Case Report. 152
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 151
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 150
Delayed gastric emptying in functional dyspepsia 149
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 149
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 147
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 145
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 145
Effect of muscarinic receptor blockade on canine gastric tone and compliance in vivo 144
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 143
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 143
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 142
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 141
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 141
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 141
Serotonin receptor modulators 140
Farmaci lassativi e purganti 139
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 138
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 138
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 138
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity 137
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 137
Inflammatory neuropathies of the enteric nervous system 137
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 137
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 134
Using artificial intelligence to create diverse and inclusive medical case vignettes for education 133
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 133
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 133
L'essenziale in Farmacologia Clinica 132
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 132
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 132
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 132
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 132
Sera of patients with celiac disease and neurological disorders evoke a mitochondrial-dependent apoptosis in a neuroblastoma cell line 131
Enteric neuroplasticity evoked by inflammation 131
Totale 17.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.205 0 0 0 0 0 253 90 202 265 180 209 1.006
2021/20224.483 556 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.512 446 555 300 564 309 314 211 286 764 194 388 181
2023/20241.573 129 218 141 167 151 239 67 116 54 113 105 73
2024/20255.333 296 866 619 296 843 319 349 202 142 316 172 913
2025/20265.617 955 1.093 1.206 844 1.429 90 0 0 0 0 0 0
Totale 31.959